These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 16056392
1. The vagus nerve and the nicotinic anti-inflammatory pathway. Ulloa L. Nat Rev Drug Discov; 2005 Aug; 4(8):673-84. PubMed ID: 16056392 [Abstract] [Full Text] [Related]
2. The neuronal strategy for inflammation. Ulloa L, Wang P. Novartis Found Symp; 2007 Aug; 280():223-33; discussion 233-7. PubMed ID: 17380797 [Abstract] [Full Text] [Related]
3. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. de Jonge WJ, Ulloa L. Br J Pharmacol; 2007 Aug; 151(7):915-29. PubMed ID: 17502850 [Abstract] [Full Text] [Related]
4. The vagus nerve as a modulator of intestinal inflammation. Van Der Zanden EP, Boeckxstaens GE, de Jonge WJ. Neurogastroenterol Motil; 2009 Jan; 21(1):6-17. PubMed ID: 19140954 [Abstract] [Full Text] [Related]
5. GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation. Kox M, van Velzen JF, Pompe JC, Hoedemaekers CW, van der Hoeven JG, Pickkers P. Biochem Pharmacol; 2009 Oct 01; 78(7):863-72. PubMed ID: 19576181 [Abstract] [Full Text] [Related]
6. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ. Nature; 2003 Jan 23; 421(6921):384-8. PubMed ID: 12508119 [Abstract] [Full Text] [Related]
8. Nicotinic acetylcholine receptor α7 subunit: a novel therapeutic target for cardiovascular diseases. Liu C, Su D. Front Med; 2012 Mar 23; 6(1):35-40. PubMed ID: 22460446 [Abstract] [Full Text] [Related]
11. Increased vagal tone accounts for the observed immune paralysis in patients with traumatic brain injury. Kox M, Pompe JC, Pickkers P, Hoedemaekers CW, van Vugt AB, van der Hoeven JG. Neurology; 2008 Feb 05; 70(6):480-5. PubMed ID: 18250293 [Abstract] [Full Text] [Related]
13. Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors. Hogg RC, Bertrand D. Biochem Pharmacol; 2007 Feb 15; 73(4):459-68. PubMed ID: 16979139 [Abstract] [Full Text] [Related]
14. Can vagus nerve stimulation halt or ameliorate rheumatoid arthritis and lupus? Das UN. Lipids Health Dis; 2011 Jan 24; 10():19. PubMed ID: 21261967 [Abstract] [Full Text] [Related]
15. Nicotine: does it have a role in the treatment of skin disease? Ingram JR. Postgrad Med J; 2009 Apr 24; 85(1002):196-201. PubMed ID: 19417169 [Abstract] [Full Text] [Related]
16. Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases. Scott DA, Martin M. World J Gastroenterol; 2006 Dec 14; 12(46):7451-9. PubMed ID: 17167832 [Abstract] [Full Text] [Related]
17. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors]. Miyata H. Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug 14; 28(4):149-58. PubMed ID: 18800618 [Abstract] [Full Text] [Related]
18. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. Luyer MD, Greve JW, Hadfoune M, Jacobs JA, Dejong CH, Buurman WA. J Exp Med; 2005 Oct 17; 202(8):1023-9. PubMed ID: 16216887 [Abstract] [Full Text] [Related]
19. Vagus nerve activity augments intestinal macrophage phagocytosis via nicotinic acetylcholine receptor alpha4beta2. van der Zanden EP, Snoek SA, Heinsbroek SE, Stanisor OI, Verseijden C, Boeckxstaens GE, Peppelenbosch MP, Greaves DR, Gordon S, De Jonge WJ. Gastroenterology; 2009 Sep 17; 137(3):1029-39, 1039.e1-4. PubMed ID: 19427310 [Abstract] [Full Text] [Related]